---
document_datetime: 2023-09-21 17:22:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/inductos-epar-all-authorised-presentations_en.pdf
document_name: inductos-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7583807
conversion_datetime: 2025-12-25 09:10:12.731451
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | (Invented) name   | Strength   | Pharmaceutical form                                | Route of administration   | Immediate Packaging                                          | <Content (concentration)>                             | Pack size                                             |
|-----------------|-------------------|------------|----------------------------------------------------|---------------------------|--------------------------------------------------------------|-------------------------------------------------------|-------------------------------------------------------|
| EU/1/02/226/001 | InductOs          | 1.5 mg/ml  | Powder, solvent and matrix for implantation matrix | Implantation              | powder: vial (glass); solvent: vial (glass); matrix: blister | Powder: 12 mg; Solvent: 10 ml Matrix: 7.5 x 10 cm     | 1 vial + 1 vial + 1 matrix + 2 syringes + 2 needles   |
| EU/1/02/226/002 | InductOs          | 1.5 mg/ml  | Powder, solvent and matrix for implantation matrix | Implantation              | powder: vial (glass); solvent: vial (glass); matrix: blister | Powder: 4 mg; Solvent: 10 ml Matrix: 2 x (2.5 x 5 cm) | 1 vial + 1 vial + 2 matrices + 2 syringes + 2 needles |